Jump to content

Anrukinzumab: Difference between revisions

Page 1
Page 2
Content deleted Content added
Script assisted update of identifiers for the Chem/Drugbox validation project (updated: 'UNII', 'CAS_number').
 
(16 intermediate revisions by 12 users not shown)
Line 1: Line 1:
{{Short description|Chemical compound}}
{{Drugbox
{{Drugbox
| Verifiedfields = changed
| type = mab
| Watchedfields = changed
| image =
| verifiedrevid = 458434000
| alt =
| mab_type = mab
| type = mab
| image =
| source = zu/o
| alt =
| target = [[Interleukin 13|IL13]]
| mab_type = mab
| tradename =
| source = zu/o
| Drugs.com =
| target = [[Interleukin 13|IL13]]
| MedlinePlus =
| tradename =
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| Drugs.com =
| pregnancy_US = <!-- A / B / C / D / X -->
| MedlinePlus =
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category=
| pregnancy_category=
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled -->
| legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, CD Lic, CD POM, CD No Reg POM, CD (Benz) POM, CD (Anab) POM or CD Inv POM -->
| legal_UK = <!-- GSL, P, POM, CD, CD Lic, CD POM, CD No Reg POM, CD (Benz) POM, CD (Anab) POM or CD Inv POM -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =
| legal_status =
| routes_of_administration =
| routes_of_administration =
| bioavailability =
| bioavailability =
| protein_bound =
| protein_bound =
| metabolism =
| metabolism =
| elimination_half-life =
| elimination_half-life =
| excretion =
| excretion =
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = <!-- blanked - oldvalue: 910649-32-0 -->
| CAS_number = 910649-32-0
| ATC_prefix = none
| ATC_prefix = none
| ATC_suffix =
| ATC_suffix =
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = OU46IGC49F
| UNII = OU46IGC49F
| PubChem =
| PubChem =
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = NA
| ChemSpiderID = none
| DrugBank =
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| C = 6452
| DrugBank =
| H = 9954
| N = 1714
| C=6452 | H=9954 | N=1714 | O=2024 | S=46
| O = 2024
| S = 46
| molecular_weight = 145.4 kDa
}}
}}


'''Anrukinzumab''' (IMA-638<ref name="IMA-638">{{cite web |url=http://www.wyeth.com/research/projects |title=Wyeth.com {{!}} Complete Project Listing | year = 2008 |publisher = [[Wyeth]]|accessdate=November 19, 2008 |archiveurl = http://web.archive.org/web/20080612044330/http://www.wyeth.com/research/projects |archivedate = June 12, 2008}}</ref>) is a humanized monoclonal antibody designed for the treatment of [[asthma]].<ref>[http://www.ama-assn.org/resources/doc/usan/anrukinzumab.pdf ''Statement On A Nonproprietary Name Adopted By The USAN Council: Anrukinzumab''], [[American Medical Association]].</ref>
'''Anrukinzumab''' (IMA-638<ref name="IMA-638">{{cite web|url=http://www.wyeth.com/research/projects |title=Wyeth.com {{!}} Complete Project Listing |year=2008 |publisher=[[Wyeth]] |access-date=November 19, 2008 |archive-url=https://web.archive.org/web/20080612044330/http://www.wyeth.com/research/projects |archive-date=June 12, 2008 |url-status=dead }}</ref>) is a humanized monoclonal antibody designed for the treatment of [[asthma]].<ref>[http://www.ama-assn.org/resources/doc/usan/anrukinzumab.pdf ''Statement On A Nonproprietary Name Adopted By The USAN Council: Anrukinzumab''], [[American Medical Association]].</ref>


Anrukinzumab was developed by [[Wyeth]].
Anrukinzumab was developed by [[Wyeth]].
Line 44: Line 47:
== References ==
== References ==
<references/>
<references/>

{{Monoclonals for immune system}}
{{Interleukin receptor modulators}}

[[Category:Drugs developed by Wyeth]]
[[Category:Abandoned drugs]]


{{monoclonal-antibody-stub}}
{{monoclonal-antibody-stub}}
{{monoclonals for immune system}}
[[Category:Wyeth]]